Natera [NTRA] vs Iqvia Holdings [IQV] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Natera wins in 5 metrics, Iqvia Holdings wins in 13 metrics, with 0 ties. Iqvia Holdings appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricNateraIqvia HoldingsBetter
P/E Ratio (TTM)-109.7329.90Natera
Price-to-Book Ratio18.376.08Iqvia Holdings
Debt-to-Equity Ratio15.74272.12Natera
PEG Ratio-0.75-1.35Iqvia Holdings
EV/EBITDA-84.5216.66Natera
Profit Margin (TTM)-12.89%7.88%Iqvia Holdings
Operating Margin (TTM)-20.19%13.39%Iqvia Holdings
EBITDA Margin (TTM)N/A13.39%N/A
Return on Equity-24.32%19.79%Iqvia Holdings
Return on Assets (TTM)-11.21%5.16%Iqvia Holdings
Free Cash Flow (TTM)$58.75M$2.11BIqvia Holdings
1-Year Return28.89%-10.57%Natera
Price-to-Sales Ratio (TTM)11.692.24Iqvia Holdings
Enterprise Value$22.15B$48.69BIqvia Holdings
EV/Revenue Ratio11.283.10Iqvia Holdings
Gross Profit Margin (TTM)63.41%32.94%Natera
Revenue per Share (TTM)$15$89Iqvia Holdings
Earnings per Share (Diluted)$-1.91$6.91Iqvia Holdings
Beta (Stock Volatility)1.741.33Iqvia Holdings
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Natera vs Iqvia Holdings Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Natera0.51%2.69%-0.11%3.46%20.65%4.20%
Iqvia Holdings-0.78%13.45%9.24%26.20%33.99%5.07%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Natera28.89%291.28%127.44%1,665.30%829.72%829.72%
Iqvia Holdings-10.57%18.23%24.59%186.46%383.65%383.65%

News Based Sentiment: Natera vs Iqvia Holdings

Natera

News based Sentiment: MIXED

Natera reported a revenue beat but an EPS miss, showcasing a classic growth company dynamic. Positive clinical trial enrollment and validation data are offset by insider selling and mixed institutional activity, creating a balanced, albeit complex, investment picture.

View Natera News Sentiment Analysis

Iqvia Holdings

News based Sentiment: POSITIVE

IQVIA delivered a strong Q2 performance, raised its full-year guidance, and saw increased analyst and institutional confidence. While insider selling is a minor concern, the overall narrative for the month is positive, suggesting continued growth and investment potential.

View Iqvia Holdings News Sentiment Analysis

Performance & Financial Health Analysis: Natera vs Iqvia Holdings

MetricNTRAIQV
Market Information
Market Cap i$22.97B$36.03B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,304,2301,417,620
90 Day Avg. Volume i1,056,8371,292,383
Last Close$171.86$205.02
52 Week Range$92.14 - $183.00$134.65 - $237.34
% from 52W High-6.09%-13.62%
All-Time High$183.00 (Jan 13, 2025)$285.61 (Dec 27, 2021)
% from All-Time High-6.09%-28.22%
Growth Metrics
Quarterly Revenue Growth0.32%0.05%
Quarterly Earnings GrowthN/A-0.27%
Financial Health
Profit Margin (TTM) i-0.13%0.08%
Operating Margin (TTM) i-0.20%0.13%
Return on Equity (TTM) i-0.24%0.20%
Debt to Equity (MRQ) i15.74272.12
Cash & Liquidity
Book Value per Share (MRQ)$9.11$33.99
Cash per Share (MRQ)$7.40$12.87
Operating Cash Flow (TTM) i$186.70M$2.62B
Levered Free Cash Flow (TTM) i$149.53M$2.45B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Natera vs Iqvia Holdings

MetricNTRAIQV
Price Ratios
P/E Ratio (TTM) i-109.7329.90
Forward P/E i-138.3117.12
PEG Ratio i-0.75-1.35
Price to Sales (TTM) i11.692.24
Price to Book (MRQ) i18.376.08
Market Capitalization
Market Capitalization i$22.97B$36.03B
Enterprise Value i$22.15B$48.69B
Enterprise Value Metrics
Enterprise to Revenue i11.283.10
Enterprise to EBITDA i-84.5216.66
Risk & Other Metrics
Beta i1.741.33
Book Value per Share (MRQ) i$9.11$33.99

Financial Statements Comparison: Natera vs Iqvia Holdings

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)NTRAIQV
Revenue/Sales i$546.60M$4.02B
Cost of Goods Sold i$200.00M$2.69B
Gross Profit i$346.60M$1.32B
Research & Development i$146.43MN/A
Operating Income (EBIT) i$-110.37M$538.00M
EBITDA i$-89.78M$813.00M
Pre-Tax Income i$-100.66M$323.00M
Income Tax i$275,000$56.00M
Net Income (Profit) i$-100.94M$266.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)NTRAIQV
Cash & Equivalents i$973.77M$2.04B
Total Current Assets i$1.42B$6.35B
Total Current Liabilities i$365.68M$7.57B
Long-Term Debt i$103.06M$14.39B
Total Shareholders Equity i$1.24B$5.79B
Retained Earnings i$-2.63B$6.58B
Property, Plant & Equipment i$94.63M$816.00M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)NTRAIQV
Operating Cash Flow i$12.99M$459.00M
Capital Expenditures i$-21.82M$-151.00M
Free Cash Flow i$22.64M$292.00M
Debt Repayment iN/A$-1.74B
Common Stock Repurchase iN/A$-657.00M

Short Interest & Institutional Ownership Analysis

MetricNTRAIQV
Shares Short i3.79M4.68M
Short Ratio i3.753.92
Short % of Float i0.03%0.03%
Average Daily Volume (10 Day) i1,304,2301,417,620
Average Daily Volume (90 Day) i1,056,8371,292,383
Shares Outstanding i132.65M176.10M
Float Shares i132.93M161.46M
% Held by Insiders i0.03%0.01%
% Held by Institutions i0.96%1.02%

Dividend Analysis & Yield Comparison: Natera vs Iqvia Holdings

MetricNTRAIQV
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A